生物反馈疗法改善原发性高血压患者述情障碍的效果

目的观察生物反馈疗法改善原发性高血压患者述情障碍的效果。方法使用多伦多述情障碍量表(Toronto Alex-ithymia Scale-20,TAS-20)筛选有述情障碍的原发性高血压患者60例,根据随机数字表分为两组(每组各30例),对照组采用常规治疗及护理,观察组在此基础上采用生物反馈治疗,4周后再次评估两组患者的述情障碍及血压。结果组间比较:治疗前,两组患者的TAS-20评分及血压值差异均无统计学意义(P>0.05);治疗4周后,观察组TAS-20评分及血压值均低于对照组,差异有统计学意义(P<0.05或P<0.01)。组内比较:观察组患者治疗前后TAS-20评分及血压值差异均有统计学意义(P<0.01);对照组治疗前后TAS-20评分差异无统计学意义(P>0.05),血压值差异有统计学意义(P<0.01)。结论生物反馈治疗改善原发性高血压患者述情障碍的疗效显著,且能增加降压治疗的效果,可考虑作为一种辅助手段应用于高血压患者的治疗及护理。

Efficacy of Biofeedback Therapy for Alexithymia of Patients with Primary Hypertension

Objective To observe the efficacy of biofeedback therapy in treating alexithymia of patients with primary hypertension.MethodsToronto Alexithymia Scale-20（TAS-20）was used to assess the alexithymia of 60 hypertension patients.The 60 patients were randomized into observational group（n=30） and control group（n=30）.Patients in the control group underwent the routine treatment and nursing.The patients in the observational group received biofeedback therapy in addition to the routine treatment.The alexithymia and blood pressure were evaluated 4 weeks after the treatment.ResultsComparison among groups： The TAS-20 scores of the observational group were not significantly different from those of the control group before treatment（P〉0.05）.After 4 weeks’ treatment,the TAS-20 total scores and blood pressure values in the observational group were significantly lower than those in the control group（P0.05）,however,significant differences were observed on the blood pressure values in the control group after the treatment（P〈0.01）.ConclusionBiofeedback therapy,a valuable alternative or adjunct traditional management for hypertension patients with alexithymia,can effectively improve the patients’ alexithymia and decrease blood pressure.